CAPR - Capricor Therapeutics Inc. (CAPR) CEO Linda Marban on Q4 2021 Results - Earnings Call Transcript
Capricor Therapeutics, Inc. (CAPR) Q4 2021 Earnings Conference Call March 10, 2022 4:30 PM ET Company Participants AJ Bergmann - Chief Financial Officer Linda Marban - Chief Executive Officer Conference Call Participants Emanuela Branchetti - H.C. Wainwright Presentation Operator 00:05 Good day, and welcome to the Capricor Therapeutics Incorporated Fourth Quarter and Full-Year 2021 Earnings Call. Today's conference is being recorded. 00:13 At this time, I would like to turn the conference over to Mr. AJ Bergmann, Chief Financial Officer. Please go ahead, sir. AJ Bergmann 00:20 Thank you. Before we start, I would like to state that we will be making certain forward-looking statements during today’s presentation. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our product candidates, our future research and development plans, including our anticipated conduct and timing of preclinical and clinical studies, our plans to present or report
For further details see:
Capricor Therapeutics, Inc. (CAPR) CEO Linda Marban on Q4 2021 Results - Earnings Call Transcript